Przejdź do zawartości
Merck

Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.

Drug intelligence & clinical pharmacy (1982-02-01)
T B Vree, C A Hekster, E van der Kleijn
MATERIAŁY
Numer produktu
Marka
Opis produktu

Sulfamethoxazole impurity A, European Pharmacopoeia (EP) Reference Standard